152 related articles for article (PubMed ID: 3007903)
1. An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla.
Meeley MP; Ernsberger PR; Granata AR; Reis DJ
Life Sci; 1986 Mar; 38(12):1119-26. PubMed ID: 3007903
[TBL] [Abstract][Full Text] [Related]
2. An endogenous substance with clonidine-like properties: selective binding to imidazole sites in the ventrolateral medulla.
Ernsberger P; Meeley MP; Reis DJ
Brain Res; 1988 Feb; 441(1-2):309-18. PubMed ID: 2834001
[TBL] [Abstract][Full Text] [Related]
3. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla.
Ernsberger P; Giuliano R; Willette RN; Reis DJ
J Pharmacol Exp Ther; 1990 Apr; 253(1):408-18. PubMed ID: 2158551
[TBL] [Abstract][Full Text] [Related]
4. Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla.
Ernsberger P; Meeley MP; Mann JJ; Reis DJ
Eur J Pharmacol; 1987 Jan; 134(1):1-13. PubMed ID: 3030779
[TBL] [Abstract][Full Text] [Related]
5. Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha-2-adrenergic receptors in the rostral ventrolateral medulla.
Ernsberger P; Giuliano R; Willette RN; Granata AR; Reis DJ
J Hypertens Suppl; 1988 Dec; 6(4):S554-7. PubMed ID: 2853758
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular responses to agmatine, a clonidine-displacing substance, in anesthetized rat.
Sun MK; Regunathan S; Reis DJ
Clin Exp Hypertens; 1995; 17(1-2):115-28. PubMed ID: 7735262
[TBL] [Abstract][Full Text] [Related]
7. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P
J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087
[TBL] [Abstract][Full Text] [Related]
8. Agmatine: an endogenous clonidine-displacing substance in the brain.
Li G; Regunathan S; Barrow CJ; Eshraghi J; Cooper R; Reis DJ
Science; 1994 Feb; 263(5149):966-9. PubMed ID: 7906055
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness of α2-adrenoceptor/I1-imidazoline receptor in the rostral ventrolateral medulla to cardiovascular regulation is enhanced in conscious spontaneously hypertensive rat.
Yamazato M; Nakamoto M; Sakima A; Yamazato Y; Takishita S; Ohya Y
Clin Exp Hypertens; 2019; 41(3):255-262. PubMed ID: 29764227
[TBL] [Abstract][Full Text] [Related]
10. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
Wang X; Li G; Abdel-Rahman AA
Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
[TBL] [Abstract][Full Text] [Related]
11. Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area.
Gomez RE; Ernsberger P; Feinland G; Reis DJ
Eur J Pharmacol; 1991 Mar; 195(2):181-91. PubMed ID: 1651861
[TBL] [Abstract][Full Text] [Related]
12. An endogenous brain substance, CDS (clonidine-displacing-substance), inhibits the twitch response of rat vas deferens.
Diamant S; Atlas D
Biochem Biophys Res Commun; 1986 Jan; 134(1):184-90. PubMed ID: 3004427
[TBL] [Abstract][Full Text] [Related]
13. Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substance.
Ernsberger P; Feinland G; Meeley MP; Reis DJ
Am J Hypertens; 1990 Feb; 3(2):90-7. PubMed ID: 2155003
[TBL] [Abstract][Full Text] [Related]
14. Imidazole receptors and clonidine-displacing substance in relationship to control of blood pressure, neuroprotection, and adrenomedullary secretion.
Reis DJ; Regunathan S; Meeley MP
Am J Hypertens; 1992 Apr; 5(4 Pt 2):51S-57S. PubMed ID: 1596395
[TBL] [Abstract][Full Text] [Related]
15. Isolation of an endogenous clonidine-displacing substance from rat brain.
Atlas D; Burstein Y
FEBS Lett; 1984 May; 170(2):387-90. PubMed ID: 6327389
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors.
Piletz JE; Chikkala DN; Ernsberger P
J Pharmacol Exp Ther; 1995 Feb; 272(2):581-7. PubMed ID: 7853171
[TBL] [Abstract][Full Text] [Related]
17. Molecular and physiological properties of clonidine-displacing substance.
Atlas D
Ann N Y Acad Sci; 1995 Jul; 763():314-24. PubMed ID: 7677341
[TBL] [Abstract][Full Text] [Related]
18. Endogenous ligands of imidazoline receptors: classic and immunoreactive clonidine-displacing substance and agmatine.
Reis DJ; Li G; Regunathan S
Ann N Y Acad Sci; 1995 Jul; 763():295-313. PubMed ID: 7677340
[TBL] [Abstract][Full Text] [Related]
19. The brain's own clonidine: purification and characterization of endogenous clonidine displacing substance from brain.
Atlas D; Diamant S; Fales HM; Pannell L
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S122-7. PubMed ID: 2455163
[TBL] [Abstract][Full Text] [Related]
20. Clonidine-displacing substance from bovine brain binds to imidazoline receptors and releases catecholamines in adrenal chromaffin cells.
Regunathan S; Meeley MP; Reis DJ
Mol Pharmacol; 1991 Dec; 40(6):884-8. PubMed ID: 1758440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
